Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

48.71 +1.65 (+3.51%)
Official Closing Price Updated: 7:00 PM EST, Nov 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 17,834,818
Open 48.53
Bid (Size) 48.70 (100)
Ask (Size) 48.87 (100)
Prev. Close 47.06
Today's Range 48.18 - 49.03
52wk Range 43.08 - 112.52
Shares Outstanding N/A
Dividend Yield 4.51%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Prediction: This Undervalued Stock Could Compete With Novo Nordisk by 2029 ↗
The mid-cap biotech could become a notable player in the industry's hottest therapeutic area. 
Via The Motley Fool
News headline image
Biotech Bull ETF Surges To 20-Month High: Analysts Say Medicare’s Drug-Pricing Blow Is Softer Than Feared ↗
Pricing updates for major therapies from Novo Nordisk, Teva, AbbVie, and others eased sector worries. 
Via Stocktwits
Topics ETFs

Performance

YTD
-44.3%
-44.3%
1 Month
-7.9%
-7.9%
3 Month
-13.7%
-13.7%
6 Month
-29.0%
-29.0%
1 Year
-54.1%
-54.1%

More News

Read More
News headline image
JPMorgan Says 2027 Medicare Drug Prices Signal Up To 40% Cuts Ahead — Novo Nordisk And Teva Stand Out As Top Targets ↗
Via Stocktwits
Topics Economy Government
News headline image
Why Novo Nordisk Stock Is Moving Higher Today ↗
Via The Motley Fool
Topics Stocks
Novo Nordisk’s Experimental GLP-1 Drug Shows Weight Loss, Blood Sugar Levels Reduction In Study ↗
Via Stocktwits
Novo Nordisk Stock Tumbles: HSBC Downgrades After ‘Lottery Ticket’ Alzheimer’s Bet Fails, But Retail Traders Call Selloff ‘Ridiculous’ ↗
Via Stocktwits
Novo’s Obesity Drug Patients Granted Compensation In Denmark Over Rare Eye Disease Linked To Wegovy, Ozempic ↗
Via Stocktwits
News headline image
Medicare Slashes Ozempic's Price Tag 71%; Why Novo Nordisk Rallied ↗
Via Investor's Business Daily
Topics Economy Government
News headline image
Did Pfizer Just Say "Checkmate" to Novo Nordisk? ↗
Via The Motley Fool
News headline image
Retail Traders Crown Novo Nordisk As Long-Term Weight Loss King — Even As Eli Lilly Hits $1T And Viking Fans Tout ‘M&A Prize’ ↗
Via Stocktwits
News headline image
Here's Why Novo Nordisk Stock Popped Today ↗
Via The Motley Fool
News headline image
Novo Nordisk (NYSE:NVO) Presents a Compelling Case for Value Investors ↗
Via Chartmill
News headline image
Why Novo Nordisk Stock Sank 5.6% Today ↗
Via The Motley Fool
Topics Stocks
News headline image
Hims, Block, and NRG Just Launched Huge Stock Buybacks ↗
Via MarketBeat
News headline image
Biggest Stock Movers Today, Nov. 24: AVGO, NVO, & More ↗
Via The Motley Fool
Topics Artificial Intelligence Government Stocks
News headline image
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
Novo Nordisk’s Blockbuster Drug Fails To Slow Alzheimer’s Disease Progression In Studies ↗
Via Stocktwits
News headline image
Novo Nordisk Just Took a Big Swing, Slashing Its GLP-1 Drug Prices. Will It Pay Off for the Healthcare Giant? ↗
Via The Motley Fool
Topics Government
News headline image
2 Major Stocks Want to Dominate the GLP-1 Market. Which One Looks Like the Leader Heading Into 2026? ↗
Via The Motley Fool
News headline image
3 Top Dividend Stocks to Buy in November ↗
Via The Motley Fool
Topics Bonds Economy
News headline image
Big News for Novo Nordisk Stock Investors ↗
Via The Motley Fool
News headline image
What's Going On With Novo Nordisk Stock? ↗
Via The Motley Fool
News headline image
Vanda Reports Big Win In Wegovy Support Study, Analysts Upbeat ↗
Via Benzinga
News headline image
KeyCorp Delivers Sobering Outlook for LifeMD, Slashing Price Target Amidst Operational Headwinds
Via MarketMinute
News headline image
Novo Nordisk Just Made a Big Move in the Weight Loss Drug Market. Should You Worry About Rival Eli Lilly? ↗
Via The Motley Fool

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 48.71
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 11/26/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.